A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer, University of Michigan Health System, at the 2018 American College of Cardiology (ACC) meeting. For more information, read the article "Understanding Contrast-Induced Nephropathy." He discusses various strategies to help reduce iodine contrast use in the cath lab to better protect patients from CIN.
Related CIN Content:
VIDEO: Strategies to Avoid Acute Kidney Injury Caused by Cath Lab Contrast — Interview with Roxana Mehran, M.D.
VIDEO: Combating Contrast Induced Nephropathy in the POSEIDON Trial — Presntation by Sonjot Brar, M.D.